オーロラキナーゼAの世界市場（～2026年）

• 英文タイトル：Global Aurora Kinase A Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY02734 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はオーロラキナーゼAのグローバル市場について調査・分析したレポートです。種類別（AMG-900、Danusertib、ENMD-2076、Ilorasertib、その他）市場規模、用途別（卵巣がん、未分化大細胞リンパ腫、脳腫瘍、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別オーロラキナーゼAの競争状況、市場シェア ・世界のオーロラキナーゼA市場：種類別市場規模 2015年-2020年（AMG-900、Danusertib、ENMD-2076、Ilorasertib、その他） ・世界のオーロラキナーゼA市場：種類別市場規模予測 2021年-2026年（AMG-900、Danusertib、ENMD-2076、Ilorasertib、その他） ・世界のオーロラキナーゼA市場：用途別市場規模 2015年-2020年（卵巣がん、未分化大細胞リンパ腫、脳腫瘍、その他） ・世界のオーロラキナーゼA市場：用途別市場規模予測 2021年-2026年（卵巣がん、未分化大細胞リンパ腫、脳腫瘍、その他） ・北米のオーロラキナーゼA市場分析：米国、カナダ ・ヨーロッパのオーロラキナーゼA市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのオーロラキナーゼA市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のオーロラキナーゼA市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのオーロラキナーゼA市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie Inc.、Amgen Inc.、Astex Pharmaceuticals, Inc.、CASI Pharmaceuticals Inc.、Merck & Co., Inc.、Millennium Pharmaceuticals, Inc.、Sanofi、Sareum Holdings Plc、Sigma-Tau S.p.A.、Taiho Pharmaceutical Co., Ltd.、Vertex Pharmaceuticals Incorporated、Vichem Chemie Research Ltd. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Aurora Kinase A Market
The global Aurora Kinase A market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Aurora Kinase A Scope and Market Size
Aurora Kinase A market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aurora Kinase A market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Aurora Kinase A market is segmented into
AMG-900
Danusertib
ENMD-2076
Ilorasertib
Others

Segment by Application, the Aurora Kinase A market is segmented into
Ovarian Cancer
Anaplastic Large Cell Lymphoma
Brain Tumor
Others

Regional and Country-level Analysis
The Aurora Kinase A market is analysed and market size information is provided by regions (countries).
The key regions covered in the Aurora Kinase A market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Aurora Kinase A Market Share Analysis
Aurora Kinase A market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Aurora Kinase A business, the date to enter into the Aurora Kinase A market, Aurora Kinase A product introduction, recent developments, etc.

The major vendors covered:
AbbVie Inc.
Amgen Inc.
Astex Pharmaceuticals, Inc.
CASI Pharmaceuticals Inc.
Merck & Co., Inc.
Millennium Pharmaceuticals, Inc.
Sanofi
Sareum Holdings Plc
Sigma-Tau S.p.A.
Taiho Pharmaceutical Co., Ltd.
Vertex Pharmaceuticals Incorporated
Vichem Chemie Research Ltd.

レポート目次

---

1 Study Coverage
1.1 Aurora Kinase A Product Introduction
1.2 Market Segments
1.3 Key Aurora Kinase A Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Aurora Kinase A Market Size Growth Rate by Type
1.4.2 AMG-900
1.4.3 Danusertib
1.4.4 ENMD-2076
1.4.5 Ilorasertib
1.4.6 Others
1.5 Market by Application
1.5.1 Global Aurora Kinase A Market Size Growth Rate by Application
1.5.2 Ovarian Cancer
1.5.3 Anaplastic Large Cell Lymphoma
1.5.4 Brain Tumor
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Aurora Kinase A Market Size, Estimates and Forecasts
2.1.1 Global Aurora Kinase A Revenue 2015-2026
2.1.2 Global Aurora Kinase A Sales 2015-2026
2.2 Global Aurora Kinase A, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Aurora Kinase A Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Aurora Kinase A Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Aurora Kinase A Competitor Landscape by Players
3.1 Aurora Kinase A Sales by Manufacturers
3.1.1 Aurora Kinase A Sales by Manufacturers (2015-2020)
3.1.2 Aurora Kinase A Sales Market Share by Manufacturers (2015-2020)
3.2 Aurora Kinase A Revenue by Manufacturers
3.2.1 Aurora Kinase A Revenue by Manufacturers (2015-2020)
3.2.2 Aurora Kinase A Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Aurora Kinase A Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Aurora Kinase A Revenue in 2019
3.2.5 Global Aurora Kinase A Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Aurora Kinase A Price by Manufacturers
3.4 Aurora Kinase A Manufacturing Base Distribution, Product Types
3.4.1 Aurora Kinase A Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Aurora Kinase A Product Type
3.4.3 Date of International Manufacturers Enter into Aurora Kinase A Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Aurora Kinase A Market Size by Type (2015-2020)
4.1.1 Global Aurora Kinase A Sales by Type (2015-2020)
4.1.2 Global Aurora Kinase A Revenue by Type (2015-2020)
4.1.3 Aurora Kinase A Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Aurora Kinase A Market Size Forecast by Type (2021-2026)
4.2.1 Global Aurora Kinase A Sales Forecast by Type (2021-2026)
4.2.2 Global Aurora Kinase A Revenue Forecast by Type (2021-2026)
4.2.3 Aurora Kinase A Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Aurora Kinase A Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Aurora Kinase A Market Size by Application (2015-2020)
5.1.1 Global Aurora Kinase A Sales by Application (2015-2020)
5.1.2 Global Aurora Kinase A Revenue by Application (2015-2020)
5.1.3 Aurora Kinase A Price by Application (2015-2020)
5.2 Aurora Kinase A Market Size Forecast by Application (2021-2026)
5.2.1 Global Aurora Kinase A Sales Forecast by Application (2021-2026)
5.2.2 Global Aurora Kinase A Revenue Forecast by Application (2021-2026)
5.2.3 Global Aurora Kinase A Price Forecast by Application (2021-2026)

6 North America
6.1 North America Aurora Kinase A by Country
6.1.1 North America Aurora Kinase A Sales by Country
6.1.2 North America Aurora Kinase A Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Aurora Kinase A Market Facts & Figures by Type
6.3 North America Aurora Kinase A Market Facts & Figures by Application

7 Europe
7.1 Europe Aurora Kinase A by Country
7.1.1 Europe Aurora Kinase A Sales by Country
7.1.2 Europe Aurora Kinase A Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Aurora Kinase A Market Facts & Figures by Type
7.3 Europe Aurora Kinase A Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Aurora Kinase A by Region
8.1.1 Asia Pacific Aurora Kinase A Sales by Region
8.1.2 Asia Pacific Aurora Kinase A Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Aurora Kinase A Market Facts & Figures by Type
8.3 Asia Pacific Aurora Kinase A Market Facts & Figures by Application

9 Latin America
9.1 Latin America Aurora Kinase A by Country
9.1.1 Latin America Aurora Kinase A Sales by Country
9.1.2 Latin America Aurora Kinase A Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Aurora Kinase A Market Facts & Figures by Type
9.3 Central & South America Aurora Kinase A Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Aurora Kinase A by Country
10.1.1 Middle East and Africa Aurora Kinase A Sales by Country
10.1.2 Middle East and Africa Aurora Kinase A Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Aurora Kinase A Market Facts & Figures by Type
10.3 Middle East and Africa Aurora Kinase A Market Facts & Figures by Application

11 Company Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Corporation Information
11.1.2 AbbVie Inc. Description and Business Overview
11.1.3 AbbVie Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc. Aurora Kinase A Products Offered
11.1.5 AbbVie Inc. Related Developments
11.2 Amgen Inc.
11.2.1 Amgen Inc. Corporation Information
11.2.2 Amgen Inc. Description and Business Overview
11.2.3 Amgen Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Inc. Aurora Kinase A Products Offered
11.2.5 Amgen Inc. Related Developments
11.3 Astex Pharmaceuticals, Inc.
11.3.1 Astex Pharmaceuticals, Inc. Corporation Information
11.3.2 Astex Pharmaceuticals, Inc. Description and Business Overview
11.3.3 Astex Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Astex Pharmaceuticals, Inc. Aurora Kinase A Products Offered
11.3.5 Astex Pharmaceuticals, Inc. Related Developments
11.4 CASI Pharmaceuticals Inc.
11.4.1 CASI Pharmaceuticals Inc. Corporation Information
11.4.2 CASI Pharmaceuticals Inc. Description and Business Overview
11.4.3 CASI Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 CASI Pharmaceuticals Inc. Aurora Kinase A Products Offered
11.4.5 CASI Pharmaceuticals Inc. Related Developments
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Corporation Information
11.5.2 Merck & Co., Inc. Description and Business Overview
11.5.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merck & Co., Inc. Aurora Kinase A Products Offered
11.5.5 Merck & Co., Inc. Related Developments
11.6 Millennium Pharmaceuticals, Inc.
11.6.1 Millennium Pharmaceuticals, Inc. Corporation Information
11.6.2 Millennium Pharmaceuticals, Inc. Description and Business Overview
11.6.3 Millennium Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Millennium Pharmaceuticals, Inc. Aurora Kinase A Products Offered
11.6.5 Millennium Pharmaceuticals, Inc. Related Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description and Business Overview
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Aurora Kinase A Products Offered
11.7.5 Sanofi Related Developments
11.8 Sareum Holdings Plc
11.8.1 Sareum Holdings Plc Corporation Information
11.8.2 Sareum Holdings Plc Description and Business Overview
11.8.3 Sareum Holdings Plc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Sareum Holdings Plc Aurora Kinase A Products Offered
11.8.5 Sareum Holdings Plc Related Developments
11.9 Sigma-Tau S.p.A.
11.9.1 Sigma-Tau S.p.A. Corporation Information
11.9.2 Sigma-Tau S.p.A. Description and Business Overview
11.9.3 Sigma-Tau S.p.A. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sigma-Tau S.p.A. Aurora Kinase A Products Offered
11.9.5 Sigma-Tau S.p.A. Related Developments
11.10 Taiho Pharmaceutical Co., Ltd.
11.10.1 Taiho Pharmaceutical Co., Ltd. Corporation Information
11.10.2 Taiho Pharmaceutical Co., Ltd. Description and Business Overview
11.10.3 Taiho Pharmaceutical Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Products Offered
11.10.5 Taiho Pharmaceutical Co., Ltd. Related Developments
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Corporation Information
11.1.2 AbbVie Inc. Description and Business Overview
11.1.3 AbbVie Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Inc. Aurora Kinase A Products Offered
11.1.5 AbbVie Inc. Related Developments
11.12 Vichem Chemie Research Ltd.
11.12.1 Vichem Chemie Research Ltd. Corporation Information
11.12.2 Vichem Chemie Research Ltd. Description and Business Overview
11.12.3 Vichem Chemie Research Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Vichem Chemie Research Ltd. Products Offered
11.12.5 Vichem Chemie Research Ltd. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Aurora Kinase A Market Estimates and Projections by Region
12.1.1 Global Aurora Kinase A Sales Forecast by Regions 2021-2026
12.1.2 Global Aurora Kinase A Revenue Forecast by Regions 2021-2026
12.2 North America Aurora Kinase A Market Size Forecast (2021-2026)
12.2.1 North America: Aurora Kinase A Sales Forecast (2021-2026)
12.2.2 North America: Aurora Kinase A Revenue Forecast (2021-2026)
12.2.3 North America: Aurora Kinase A Market Size Forecast by Country (2021-2026)
12.3 Europe Aurora Kinase A Market Size Forecast (2021-2026)
12.3.1 Europe: Aurora Kinase A Sales Forecast (2021-2026)
12.3.2 Europe: Aurora Kinase A Revenue Forecast (2021-2026)
12.3.3 Europe: Aurora Kinase A Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Aurora Kinase A Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Aurora Kinase A Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Aurora Kinase A Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Aurora Kinase A Market Size Forecast by Region (2021-2026)
12.5 Latin America Aurora Kinase A Market Size Forecast (2021-2026)
12.5.1 Latin America: Aurora Kinase A Sales Forecast (2021-2026)
12.5.2 Latin America: Aurora Kinase A Revenue Forecast (2021-2026)
12.5.3 Latin America: Aurora Kinase A Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Aurora Kinase A Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Aurora Kinase A Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Aurora Kinase A Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Aurora Kinase A Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Aurora Kinase A Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Aurora Kinase A Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Aurora Kinase A Market Segments
Table 2. Ranking of Global Top Aurora Kinase A Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Aurora Kinase A Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AMG-900
Table 5. Major Manufacturers of Danusertib
Table 6. Major Manufacturers of ENMD-2076
Table 7. Major Manufacturers of Ilorasertib
Table 8. Major Manufacturers of Others
Table 9. Global Aurora Kinase A Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Aurora Kinase A Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Aurora Kinase A Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Aurora Kinase A Sales Market Share by Regions (2015-2020)
Table 13. Global Aurora Kinase A Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Aurora Kinase A Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Aurora Kinase A Sales Share by Manufacturers (2015-2020)
Table 16. Global Aurora Kinase A Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Aurora Kinase A by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aurora Kinase A as of 2019)
Table 18. Aurora Kinase A Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Aurora Kinase A Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Aurora Kinase A Price (2015-2020) (USD/Pcs)
Table 21. Aurora Kinase A Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Aurora Kinase A Product Type
Table 23. Date of International Manufacturers Enter into Aurora Kinase A Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Aurora Kinase A Sales by Type (2015-2020) (K Pcs)
Table 26. Global Aurora Kinase A Sales Share by Type (2015-2020)
Table 27. Global Aurora Kinase A Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Aurora Kinase A Revenue Share by Type (2015-2020)
Table 29. Aurora Kinase A Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Aurora Kinase A Sales by Application (2015-2020) (K Pcs)
Table 31. Global Aurora Kinase A Sales Share by Application (2015-2020)
Table 32. North America Aurora Kinase A Sales by Country (2015-2020) (K Pcs)
Table 33. North America Aurora Kinase A Sales Market Share by Country (2015-2020)
Table 34. North America Aurora Kinase A Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Aurora Kinase A Revenue Market Share by Country (2015-2020)
Table 36. North America Aurora Kinase A Sales by Type (2015-2020) (K Pcs)
Table 37. North America Aurora Kinase A Sales Market Share by Type (2015-2020)
Table 38. North America Aurora Kinase A Sales by Application (2015-2020) (K Pcs)
Table 39. North America Aurora Kinase A Sales Market Share by Application (2015-2020)
Table 40. Europe Aurora Kinase A Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Aurora Kinase A Sales Market Share by Country (2015-2020)
Table 42. Europe Aurora Kinase A Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Aurora Kinase A Revenue Market Share by Country (2015-2020)
Table 44. Europe Aurora Kinase A Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Aurora Kinase A Sales Market Share by Type (2015-2020)
Table 46. Europe Aurora Kinase A Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Aurora Kinase A Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Aurora Kinase A Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Aurora Kinase A Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Aurora Kinase A Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Aurora Kinase A Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Aurora Kinase A Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Aurora Kinase A Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Aurora Kinase A Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Aurora Kinase A Sales Market Share by Application (2015-2020)
Table 56. Latin America Aurora Kinase A Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Aurora Kinase A Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Aurora Kinase A Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Aurora Kinase A Revenue Market Share by Country (2015-2020)
Table 60. Latin America Aurora Kinase A Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Aurora Kinase A Sales Market Share by Type (2015-2020)
Table 62. Latin America Aurora Kinase A Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Aurora Kinase A Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Aurora Kinase A Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Aurora Kinase A Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Aurora Kinase A Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Aurora Kinase A Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Aurora Kinase A Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Aurora Kinase A Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Aurora Kinase A Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Aurora Kinase A Sales Market Share by Application (2015-2020)
Table 72. AbbVie Inc. Corporation Information
Table 73. AbbVie Inc. Description and Major Businesses
Table 74. AbbVie Inc. Aurora Kinase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. AbbVie Inc. Product
Table 76. AbbVie Inc. Recent Development
Table 77. Amgen Inc. Corporation Information
Table 78. Amgen Inc. Description and Major Businesses
Table 79. Amgen Inc. Aurora Kinase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Amgen Inc. Product
Table 81. Amgen Inc. Recent Development
Table 82. Astex Pharmaceuticals, Inc. Corporation Information
Table 83. Astex Pharmaceuticals, Inc. Description and Major Businesses
Table 84. Astex Pharmaceuticals, Inc. Aurora Kinase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Astex Pharmaceuticals, Inc. Product
Table 86. Astex Pharmaceuticals, Inc. Recent Development
Table 87. CASI Pharmaceuticals Inc. Corporation Information
Table 88. CASI Pharmaceuticals Inc. Description and Major Businesses
Table 89. CASI Pharmaceuticals Inc. Aurora Kinase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. CASI Pharmaceuticals Inc. Product
Table 91. CASI Pharmaceuticals Inc. Recent Development
Table 92. Merck & Co., Inc. Corporation Information
Table 93. Merck & Co., Inc. Description and Major Businesses
Table 94. Merck & Co., Inc. Aurora Kinase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Merck & Co., Inc. Product
Table 96. Merck & Co., Inc. Recent Development
Table 97. Millennium Pharmaceuticals, Inc. Corporation Information
Table 98. Millennium Pharmaceuticals, Inc. Description and Major Businesses
Table 99. Millennium Pharmaceuticals, Inc. Aurora Kinase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Millennium Pharmaceuticals, Inc. Product
Table 101. Millennium Pharmaceuticals, Inc. Recent Development
Table 102. Sanofi Corporation Information
Table 103. Sanofi Description and Major Businesses
Table 104. Sanofi Aurora Kinase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Sanofi Product
Table 106. Sanofi Recent Development
Table 107. Sareum Holdings Plc Corporation Information
Table 108. Sareum Holdings Plc Description and Major Businesses
Table 109. Sareum Holdings Plc Aurora Kinase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Sareum Holdings Plc Product
Table 111. Sareum Holdings Plc Recent Development
Table 112. Sigma-Tau S.p.A. Corporation Information
Table 113. Sigma-Tau S.p.A. Description and Major Businesses
Table 114. Sigma-Tau S.p.A. Aurora Kinase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Sigma-Tau S.p.A. Product
Table 116. Sigma-Tau S.p.A. Recent Development
Table 117. Taiho Pharmaceutical Co., Ltd. Corporation Information
Table 118. Taiho Pharmaceutical Co., Ltd. Description and Major Businesses
Table 119. Taiho Pharmaceutical Co., Ltd. Aurora Kinase A Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Taiho Pharmaceutical Co., Ltd. Product
Table 121. Taiho Pharmaceutical Co., Ltd. Recent Development
Table 122. Vertex Pharmaceuticals Incorporated Corporation Information
Table 123. Vertex Pharmaceuticals Incorporated Description and Major Businesses
Table 124. Vertex Pharmaceuticals Incorporated Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Vertex Pharmaceuticals Incorporated Product
Table 126. Vertex Pharmaceuticals Incorporated Recent Development
Table 127. Vichem Chemie Research Ltd. Corporation Information
Table 128. Vichem Chemie Research Ltd. Description and Major Businesses
Table 129. Vichem Chemie Research Ltd. Aurora Kinase A Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Vichem Chemie Research Ltd. Product
Table 131. Vichem Chemie Research Ltd. Recent Development
Table 132. Global Aurora Kinase A Sales Forecast by Regions (2021-2026) (K Pcs)
Table 133. Global Aurora Kinase A Sales Market Share Forecast by Regions (2021-2026)
Table 134. Global Aurora Kinase A Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 135. Global Aurora Kinase A Revenue Market Share Forecast by Regions (2021-2026)
Table 136. North America: Aurora Kinase A Sales Forecast by Country (2021-2026) (K Pcs)
Table 137. North America: Aurora Kinase A Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Europe: Aurora Kinase A Sales Forecast by Country (2021-2026) (K Pcs)
Table 139. Europe: Aurora Kinase A Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Asia Pacific: Aurora Kinase A Sales Forecast by Region (2021-2026) (K Pcs)
Table 141. Asia Pacific: Aurora Kinase A Revenue Forecast by Region (2021-2026) (US$ Million)
Table 142. Latin America: Aurora Kinase A Sales Forecast by Country (2021-2026) (K Pcs)
Table 143. Latin America: Aurora Kinase A Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Middle East and Africa: Aurora Kinase A Sales Forecast by Country (2021-2026) (K Pcs)
Table 145. Middle East and Africa: Aurora Kinase A Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 147. Key Challenges
Table 148. Market Risks
Table 149. Main Points Interviewed from Key Aurora Kinase A Players
Table 150. Aurora Kinase A Customers List
Table 151. Aurora Kinase A Distributors List
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Aurora Kinase A Product Picture
Figure 2. Global Aurora Kinase A Sales Market Share by Type in 2020 & 2026
Figure 3. AMG-900 Product Picture
Figure 4. Danusertib Product Picture
Figure 5. ENMD-2076 Product Picture
Figure 6. Ilorasertib Product Picture
Figure 7. Others Product Picture
Figure 8. Global Aurora Kinase A Sales Market Share by Application in 2020 & 2026
Figure 9. Ovarian Cancer
Figure 10. Anaplastic Large Cell Lymphoma
Figure 11. Brain Tumor
Figure 12. Others
Figure 13. Aurora Kinase A Report Years Considered
Figure 14. Global Aurora Kinase A Market Size 2015-2026 (US$ Million)
Figure 15. Global Aurora Kinase A Sales 2015-2026 (K Pcs)
Figure 16. Global Aurora Kinase A Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Aurora Kinase A Sales Market Share by Region (2015-2020)
Figure 18. Global Aurora Kinase A Sales Market Share by Region in 2019
Figure 19. Global Aurora Kinase A Revenue Market Share by Region (2015-2020)
Figure 20. Global Aurora Kinase A Revenue Market Share by Region in 2019
Figure 21. Global Aurora Kinase A Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Aurora Kinase A Revenue in 2019
Figure 23. Aurora Kinase A Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Aurora Kinase A Sales Market Share by Type (2015-2020)
Figure 25. Global Aurora Kinase A Sales Market Share by Type in 2019
Figure 26. Global Aurora Kinase A Revenue Market Share by Type (2015-2020)
Figure 27. Global Aurora Kinase A Revenue Market Share by Type in 2019
Figure 28. Global Aurora Kinase A Market Share by Price Range (2015-2020)
Figure 29. Global Aurora Kinase A Sales Market Share by Application (2015-2020)
Figure 30. Global Aurora Kinase A Sales Market Share by Application in 2019
Figure 31. Global Aurora Kinase A Revenue Market Share by Application (2015-2020)
Figure 32. Global Aurora Kinase A Revenue Market Share by Application in 2019
Figure 33. North America Aurora Kinase A Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Aurora Kinase A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Aurora Kinase A Sales Market Share by Country in 2019
Figure 36. North America Aurora Kinase A Revenue Market Share by Country in 2019
Figure 37. U.S. Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Aurora Kinase A Market Share by Type in 2019
Figure 42. North America Aurora Kinase A Market Share by Application in 2019
Figure 43. Europe Aurora Kinase A Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Aurora Kinase A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Aurora Kinase A Sales Market Share by Country in 2019
Figure 46. Europe Aurora Kinase A Revenue Market Share by Country in 2019
Figure 47. Germany Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Aurora Kinase A Market Share by Type in 2019
Figure 58. Europe Aurora Kinase A Market Share by Application in 2019
Figure 59. Asia Pacific Aurora Kinase A Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Aurora Kinase A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Aurora Kinase A Sales Market Share by Region in 2019
Figure 62. Asia Pacific Aurora Kinase A Revenue Market Share by Region in 2019
Figure 63. China Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Aurora Kinase A Market Share by Type in 2019
Figure 86. Asia Pacific Aurora Kinase A Market Share by Application in 2019
Figure 87. Latin America Aurora Kinase A Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Aurora Kinase A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Aurora Kinase A Sales Market Share by Country in 2019
Figure 90. Latin America Aurora Kinase A Revenue Market Share by Country in 2019
Figure 91. Mexico Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Aurora Kinase A Market Share by Type in 2019
Figure 98. Latin America Aurora Kinase A Market Share by Application in 2019
Figure 99. Middle East and Africa Aurora Kinase A Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Aurora Kinase A Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Aurora Kinase A Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Aurora Kinase A Revenue Market Share by Country in 2019
Figure 103. Turkey Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Aurora Kinase A Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Aurora Kinase A Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Aurora Kinase A Market Share by Type in 2019
Figure 110. Middle East and Africa Aurora Kinase A Market Share by Application in 2019
Figure 111. North America Aurora Kinase A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Aurora Kinase A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Aurora Kinase A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Aurora Kinase A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Aurora Kinase A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Aurora Kinase A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Aurora Kinase A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Aurora Kinase A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Aurora Kinase A Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Aurora Kinase A Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

---